These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21905662)

  • 41. Dendrimers of citric acid and poly (ethylene glycol) as the new drug-delivery agents.
    Namazi H; Adeli M
    Biomaterials; 2005 Apr; 26(10):1175-83. PubMed ID: 15451637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanotheranostics and image-guided drug delivery: current concepts and future directions.
    Lammers T; Kiessling F; Hennink WE; Storm G
    Mol Pharm; 2010 Dec; 7(6):1899-912. PubMed ID: 20822168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Real-time electrochemical monitoring of drug release from therapeutic nanoparticles.
    Mora L; Chumbimuni-Torres KY; Clawson C; Hernandez L; Zhang L; Wang J
    J Control Release; 2009 Nov; 140(1):69-73. PubMed ID: 19679152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) as doxorubicin carriers.
    Gardikis K; Tsimplouli C; Dimas K; Micha-Screttas M; Demetzos C
    Int J Pharm; 2010 Dec; 402(1-2):231-7. PubMed ID: 20934501
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Self-ordered nanopore and nanotube platforms for drug delivery applications.
    Losic D; Simovic S
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1363-81. PubMed ID: 19860534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Engineered nonviral nanocarriers for intracellular gene delivery applications.
    Ojea-Jiménez I; Tort O; Lorenzo J; Puntes VF
    Biomed Mater; 2012 Oct; 7(5):054106. PubMed ID: 22972254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perylene-3-ylmethanol: fluorescent organic nanoparticles as a single-component photoresponsive nanocarrier with real-time monitoring of anticancer drug release.
    Jana A; Devi KS; Maiti TK; Singh ND
    J Am Chem Soc; 2012 May; 134(18):7656-9. PubMed ID: 22519548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thermodynamic and structural characterization of Liposomal-Locked in-Dendrimers as drug carriers.
    Gardikis K; Hatziantoniou S; Signorelli M; Pusceddu M; Micha-Screttas M; Schiraldi A; Demetzos C; Fessas D
    Colloids Surf B Biointerfaces; 2010 Nov; 81(1):11-9. PubMed ID: 20638250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liposomes in ultrasonic drug and gene delivery.
    Huang SL
    Adv Drug Deliv Rev; 2008 Jun; 60(10):1167-76. PubMed ID: 18479776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanoparticle formulations in pulmonary drug delivery.
    Bailey MM; Berkland CJ
    Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanoparticle-mediated drug delivery and gene therapy.
    Jin S; Ye K
    Biotechnol Prog; 2007; 23(1):32-41. PubMed ID: 17269667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electrochemically controlled drug delivery based on intrinsically conducting polymers.
    Svirskis D; Travas-Sejdic J; Rodgers A; Garg S
    J Control Release; 2010 Aug; 146(1):6-15. PubMed ID: 20359512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biophysicochemical perspective of nanoparticle compatibility: a critically ignored parameter in nanomedicine.
    Hassan S; Singh AV
    J Nanosci Nanotechnol; 2014 Jan; 14(1):402-14. PubMed ID: 24730271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Present and the Future of Degradable Dendrimers and Derivatives in Theranostics.
    Leiro V; Garcia JP; Tomás H; Pêgo AP
    Bioconjug Chem; 2015 Jul; 26(7):1182-97. PubMed ID: 25826129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vesicular Systems Containing Curcumin and Their Applications in Respiratory Disorders - A Mini Review.
    Chellappan DK; Hansbro PM; Dua K; Hsu A; Gupta G; Ng ZY; Wong JY; Chellian J; Panneerselvam J
    Pharm Nanotechnol; 2017; 5(4):250-254. PubMed ID: 28786351
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultrasonically triggered drug delivery: breaking the barrier.
    Husseini GA; Pitt WG; Martins AM
    Colloids Surf B Biointerfaces; 2014 Nov; 123():364-86. PubMed ID: 25454759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein-polymer nanoreactors for medical applications.
    Palivan CG; Fischer-Onaca O; Delcea M; Itel F; Meier W
    Chem Soc Rev; 2012 Apr; 41(7):2800-23. PubMed ID: 22085991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advanced drug delivery nanosystems: perspectives and regulatory issues.
    Demetzos C
    Adv Exp Med Biol; 2015; 822():195-8. PubMed ID: 25416990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Progress of the hydrokinetic chromatography and its application in the characterization of particulate drug delivery systems].
    Liu W; Li HY; Guo Z; Zhang JW; Sun LX
    Yao Xue Xue Bao; 2011 Jun; 46(6):631-6. PubMed ID: 21882521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.